

When cancer is diagnosed, life changes dramatically.
Two fundamental wishes come into focus:
To get healthy again.
To tolerate therapy with as few side effects as possible.
The CANTREAT Principle

To get healthy again.
To tolerate therapy with as few side effects as possible.
By releasing active ingredients exclusively within the tumor, significantly higher drug concentrations can precisely target cancer cells without placing unnecessary stress on the body. This greatly reduces side effects and improves chances of recovery, even for hard-to-treat cancers.
At its core is an innovative technology using magnetically controlled nanoparticles. These particles are covered with a specialized shell, developed by CANTREAT researchers, enabling approved cytostatic drugs to attach without chemical modification.
The nanoparticles are injected directly into the tumor’s artery and precisely guided into tumor tissue using an external magnetic system. The integrated magnetic core anchors the nanoparticles reliably within the targeted area.
The crucial mechanism: the special coating acts as an energy source for tumor cells. The tumor recognizes this substance and releases enzymes to metabolize it—thereby unknowingly absorbing the attached cytostatic drug directly into its cells.
Healthy tissues remain largely unaffected.
The tumor selectively absorbs the particles disguised as nutrients, enabling targeted elimination of cancer cells from within. After treatment, the magnetic core remains temporarily in the body but is swiftly recognized as foreign and safely eliminated via liver and kidneys.
CANTREAT allows up to 90% of all currently available cytostatic drugs to be applied, including potent medications previously unusable due to severe side effects.
CANTREAT AG
Wolleraustrasse 11a
8807 Freienbach SZ
Switzerland
E-Mail: info@cantreat.ch
Phone: +41 44 915 01 05